TetraLogic Pharmaceuticals (TLOG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

TetraLogic Pharmaceuticals (TLOG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TetraLogic Pharmaceuticals (TLOG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
TetraLogic Pharmaceuticals (TLOG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
28 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company that research and develops novel small molecule therapeutics in the areas of oncology and infectious diseases. The companys clinical stage products include birinapant and SHAPE. Its birinapant is a small molecule therapeutic that causes cell death in damaged cells and is used in the treatment of hematological malignancies and solid tumors. TetraLogic carries out clinical trial to investigate the safety and effectiveness of different dosing regimens of SHAPE in patients suffering from earlier stage cutaneous T-cell lymphoma.

TetraLogic Pharmaceuticals (TLOG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a

  
Source:
Document ID
GDPH135935D
Country
Industry
Ticker
TLOG=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
TetraLogic Pharmaceuticals, Pharmaceuticals &Healthcare, Deal Details1015
  Venture Financing101
    Tetralogic Pharma Raises US$5 Million In Venture Financing102
    TetraLogic Pharma Secures US$6 Million In Series C-1 Financing121
    TetraLogic Pharma Secures US$23 Million In Second Tranche Of Series C Financing132
    TetraLogic Pharma Raises US$2 Million In Venture Financing151
  Licensing Agreements161
    TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research162
  Equity Offering181
    TetraLogic Pharma Terminates Public Offering of Shares for USD25 Million182
    TetraLogic Pharma Completes Underwriters Exercise Of Over-Allotment Option For IPO For US$57.5 Million202
  Debt Offering221
    TetraLogic Pharma Raises USD47 Million in Private Placement of 8% Notes Due 2019222
  Acquisition241
    TetraLogic Pharma To Acquire Shape Pharma, Biotech Company241
TetraLogic Pharmaceuticals - Key Competitors251
Key Employees261
Locations And Subsidiaries271
  Head Office271
Appendix281
  Methodology281
  About GlobalData281
  Contact Us281
  Disclaimer281

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "TetraLogic Pharmaceuticals (TLOG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/TetraLogic-Pharmaceuticals-TLOG-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-3054>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). TetraLogic Pharmaceuticals (TLOG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/TetraLogic-Pharmaceuticals-TLOG-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-3054>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research